Skip to content

Thursday, March 23, 2023

Latest:

6 tips to prevent colon cancer
TRISH to study how the human body and mind respond to spaceflight
How to support friends with different attachment styles
A checklist for the best camping trip
Celebrating Match Day 2023

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

rhabdomyosarcoma

New insights into the mediators of patient recovery after CAR T cell immunotherapy

July 21, 2020July 28, 2020cancer therapy, CAR T cell, Clinical Trials, complete response, HER-2, Immunotherapy, Research, rhabdomyosarcoma

Clinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.

From the Labs Image of the Month

From the Labs: a transparent heart

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951